Review

keap1 kelch (Biacore)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Biacore keap1 kelch

Caffeic acid (CA) activate kelch-like ECH-associated protein 1/nuclear factor erythroid 2 related factor 2 <t>(Keap1/Nrf2)</t> signaling pathway. (A–E) Western blot and gray value analysis of Keap1 protein expression. (F) Western blot and gray value analysis of Nrf2 protein expression in the nucleus and cytoplasm. (G, H) Representative images of immunofluorescence staining of Keap1 (Green) and Nrf2 (Red). (I) Western blot and gray value analysis of heme oxygenase-1 (HO-1) and nicotinamide adenine dinucleotide phosphate (NADPH) dehydrogenase quinone 1 (NQO1) protein expression. The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group. GAPDH: glyceraldehyde-3-phosphate dehydrogenase; DAPI: 4′,6-diamidino-2′-phenylindole.

Keap1 Kelch, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/keap1+kelch/pmc12666825-336-19-28?v=Biacore
Average 86 stars, based on 1 article reviews

keap1 kelch - by Bioz Stars, 2026-07

86/100 stars

Images

1) Product Images from "Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation"

Article Title: Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation

Journal: Journal of Pharmaceutical Analysis

doi: 10.1016/j.jpha.2025.101219

Caffeic acid (CA) activate kelch-like ECH-associated protein 1/nuclear factor erythroid 2 related factor 2 (Keap1/Nrf2) signaling pathway. (A–E) Western blot and gray value analysis of Keap1 protein expression. (F) Western blot and gray value analysis of Nrf2 protein expression in the nucleus and cytoplasm. (G, H) Representative images of immunofluorescence staining of Keap1 (Green) and Nrf2 (Red). (I) Western blot and gray value analysis of heme oxygenase-1 (HO-1) and nicotinamide adenine dinucleotide phosphate (NADPH) dehydrogenase quinone 1 (NQO1) protein expression. The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group. GAPDH: glyceraldehyde-3-phosphate dehydrogenase; DAPI: 4′,6-diamidino-2′-phenylindole.

Figure Legend Snippet: Caffeic acid (CA) activate kelch-like ECH-associated protein 1/nuclear factor erythroid 2 related factor 2 (Keap1/Nrf2) signaling pathway. (A–E) Western blot and gray value analysis of Keap1 protein expression. (F) Western blot and gray value analysis of Nrf2 protein expression in the nucleus and cytoplasm. (G, H) Representative images of immunofluorescence staining of Keap1 (Green) and Nrf2 (Red). (I) Western blot and gray value analysis of heme oxygenase-1 (HO-1) and nicotinamide adenine dinucleotide phosphate (NADPH) dehydrogenase quinone 1 (NQO1) protein expression. The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group. GAPDH: glyceraldehyde-3-phosphate dehydrogenase; DAPI: 4′,6-diamidino-2′-phenylindole.

Techniques Used: Western Blot, Expressing, Immunofluorescence, Staining, Standard Deviation, Control

Caffeic acid (CA) induced kelch-like ECH-associated protein 1 (Keap1) degradation via p62-dependent autophagy. (A) Western blot and gray value analysis of Keap1 and p62 protein expression. (B) Immunofluorescence staining of p62 (Red) was analyzed by treating cells with different doses of CA. (C–E) Western blot and gray value analysis of Keap1 and LC3B-II protein expression were conducted both with and without the addition of MG132. (F–H) Western blot and gray value analysis of Keap1 and LC3B-II protein expression were conducted both with and without the addition of CQ (I) The LC3B-II (Red) expression level was detected by immunofluorescence analysis. The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group. DAPI: 4′,6-diamidino-2′-phenylindole; CQ: chloroquin.

Figure Legend Snippet: Caffeic acid (CA) induced kelch-like ECH-associated protein 1 (Keap1) degradation via p62-dependent autophagy. (A) Western blot and gray value analysis of Keap1 and p62 protein expression. (B) Immunofluorescence staining of p62 (Red) was analyzed by treating cells with different doses of CA. (C–E) Western blot and gray value analysis of Keap1 and LC3B-II protein expression were conducted both with and without the addition of MG132. (F–H) Western blot and gray value analysis of Keap1 and LC3B-II protein expression were conducted both with and without the addition of CQ (I) The LC3B-II (Red) expression level was detected by immunofluorescence analysis. The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group. DAPI: 4′,6-diamidino-2′-phenylindole; CQ: chloroquin.

Techniques Used: Western Blot, Expressing, Immunofluorescence, Staining, Standard Deviation, Control

Caffeic acid (CA) directly interacts with kelch-like ECH-associated protein 1 (Keap1) in vit r o . (A) Structure of CA and photo-affinity labeling probe (PAL-CA). (B) PAL-CA probe target fishing flowchart. (C) Silver staining of the PAL-CA complex in H9c2 cells. (D) Validation of Keap1 pulled down from mitochondria of the H9c2 cells with PAL-CA by Western blot. (E) Cellular thermal shift assay (CETSA) experiments of CA with Keap1 protein. (F) Size-exclusion chromatography analysis. The black and red lines represent the ultraviolet absorption of the standard and Keap1 proteins at 280 nM, respectively. (G) Surface plasmon resonance (SPR) experiments of CA with Keap1 protein. (H) Chemical structure of CA (top) and isothermal titration calorimetry (ITC) experiments (bottom). (I, J) SDS-PAGE gel and line graph were used to analyze the in vitro digestive stability of Keap1 under the action of trypsin.. (K) Native mass spectrometry analysis of apo Keap1. The Keap1 protein exists as monomers, dimers, and hexamers in solution (top). Enlarged view of the Keap1 protein dimer, including the P 1 and P 2 peaks (bottom). (L) Native mass spectrometry analysis of Keap1 with CA. After CA binds to the Keap1 protein, the monomers, dimers and hexamers exist in solution (top). Enlarged view of the increased dimerization that occurs after CA binds to the Keap1 protein (P 1 and P 2 peaks) (bottom). The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). DMSO: dimethyl sulfoxide.

Figure Legend Snippet: Caffeic acid (CA) directly interacts with kelch-like ECH-associated protein 1 (Keap1) in vit r o . (A) Structure of CA and photo-affinity labeling probe (PAL-CA). (B) PAL-CA probe target fishing flowchart. (C) Silver staining of the PAL-CA complex in H9c2 cells. (D) Validation of Keap1 pulled down from mitochondria of the H9c2 cells with PAL-CA by Western blot. (E) Cellular thermal shift assay (CETSA) experiments of CA with Keap1 protein. (F) Size-exclusion chromatography analysis. The black and red lines represent the ultraviolet absorption of the standard and Keap1 proteins at 280 nM, respectively. (G) Surface plasmon resonance (SPR) experiments of CA with Keap1 protein. (H) Chemical structure of CA (top) and isothermal titration calorimetry (ITC) experiments (bottom). (I, J) SDS-PAGE gel and line graph were used to analyze the in vitro digestive stability of Keap1 under the action of trypsin.. (K) Native mass spectrometry analysis of apo Keap1. The Keap1 protein exists as monomers, dimers, and hexamers in solution (top). Enlarged view of the Keap1 protein dimer, including the P 1 and P 2 peaks (bottom). (L) Native mass spectrometry analysis of Keap1 with CA. After CA binds to the Keap1 protein, the monomers, dimers and hexamers exist in solution (top). Enlarged view of the increased dimerization that occurs after CA binds to the Keap1 protein (P 1 and P 2 peaks) (bottom). The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). DMSO: dimethyl sulfoxide.

Techniques Used: Labeling, Silver Staining, Biomarker Discovery, Western Blot, Thermal Shift Assay, Size-exclusion Chromatography, SPR Assay, Isothermal Titration Calorimetry, SDS Page, In Vitro, Mass Spectrometry, Standard Deviation

The complexed crystal structure confirms the interaction sites of caffeic acid (CA) with kelch-like ECH-associated protein 1 (Keap1). (A) Schematic design of the experiments. (B) Gel filtration traces of Keap1 and Keap1 gel filtered with CA with a Superdex 200 10/300 Increase column and superimposed on the chromatogram of two standard protein markers (75 kDa and 44 kDa). (C) Kelch crystal diagram. (D) The overall structure of the complex of the Kelch domain with CA. Two orthogonal views are shown. (E) The CA molecule and surrounding residues responsible for its binding are shown in ball-and-stick representation. The M550 and N532 residues of the Kelch domain interact with CA. (F) Isothermal titration calorimetry (ITC) experiments of N532A with Keap1. (G) Comparison of the mouse Kelch domain (PDB ID: 1X2J ) and the Kelch domain bound to CA (PDB ID: 7YEN ). The Kelch apo and Kelch-CA complexes are colored wheat and purple, respectively. (H) Protein-ligand complex structure of molecular dynamics (MD) simulations for wild type 5 ns (a), wild type 100 ns (b), N532A mutant (c), and M550A mutant (d) of Keap1 kelch domain. The ligand CA is shown as yellow sticks. (I) Multiple sequence alignment of Keap1 from different species. The red background represents extremely conserved residues, and the red font represents relatively conserved residues. H. sapiens : Homo sapiens; M. musculus : Mus musculus ; C. toad : Caucasian toad ; D. rerio : Danio rerio .DP: ?.

Figure Legend Snippet: The complexed crystal structure confirms the interaction sites of caffeic acid (CA) with kelch-like ECH-associated protein 1 (Keap1). (A) Schematic design of the experiments. (B) Gel filtration traces of Keap1 and Keap1 gel filtered with CA with a Superdex 200 10/300 Increase column and superimposed on the chromatogram of two standard protein markers (75 kDa and 44 kDa). (C) Kelch crystal diagram. (D) The overall structure of the complex of the Kelch domain with CA. Two orthogonal views are shown. (E) The CA molecule and surrounding residues responsible for its binding are shown in ball-and-stick representation. The M550 and N532 residues of the Kelch domain interact with CA. (F) Isothermal titration calorimetry (ITC) experiments of N532A with Keap1. (G) Comparison of the mouse Kelch domain (PDB ID: 1X2J ) and the Kelch domain bound to CA (PDB ID: 7YEN ). The Kelch apo and Kelch-CA complexes are colored wheat and purple, respectively. (H) Protein-ligand complex structure of molecular dynamics (MD) simulations for wild type 5 ns (a), wild type 100 ns (b), N532A mutant (c), and M550A mutant (d) of Keap1 kelch domain. The ligand CA is shown as yellow sticks. (I) Multiple sequence alignment of Keap1 from different species. The red background represents extremely conserved residues, and the red font represents relatively conserved residues. H. sapiens : Homo sapiens; M. musculus : Mus musculus ; C. toad : Caucasian toad ; D. rerio : Danio rerio .DP: ?.

Techniques Used: Filtration, Binding Assay, Isothermal Titration Calorimetry, Comparison, Mutagenesis, Sequencing

Interaction analysis of caffeic acid (CA) analogs with kelch-like ECH-associated protein 1 (Keap1) Kelch . (A–D) The affinity of Keap1 Kelch binding with different components was detected by Biacore. (A) CGA with Keap1 Kelch , (B) CA-derivative with Keap1 Kelch , (C) Protocatechuic acid with Keap1 Kelch , D) Gallic acid with Keap1 Kelch . (E-H) The CA analogs and Keap1 Kelch interaction diagram. (E) Molecular docking of CGA with Keap1 Kelch , (F) Molecular docking of CA-derivative with Keap1 Kelch , (G) Molecular docking of protocatechuic acid with Keap1 Kelch , (H) Molecular docking of gallic acid with Keap1 Kelch , This figure is exported from the Ligplot software. Hydrogen bonds are shown as green dotted lines, while the spoked arcs represent residues making nonbonded contacts with the ligand. (I) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays of the toxic effects of chlorogenic acid (CGA) on H 2 O 2 -treated H9c2 cells. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to H 2 O 2 group. (J) Western blot and gray value analysis of Keap1 protein expression after treated with different concentrations of CGA. (K) Western blot and gray value analysis of Keap1 protein expression treated with different times of CGA. (L) Western blot and gray value analysis of Keap1 protein expression treated with different concentrations of 60 μM CGA. The results are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group.

Figure Legend Snippet: Interaction analysis of caffeic acid (CA) analogs with kelch-like ECH-associated protein 1 (Keap1) Kelch . (A–D) The affinity of Keap1 Kelch binding with different components was detected by Biacore. (A) CGA with Keap1 Kelch , (B) CA-derivative with Keap1 Kelch , (C) Protocatechuic acid with Keap1 Kelch , D) Gallic acid with Keap1 Kelch . (E-H) The CA analogs and Keap1 Kelch interaction diagram. (E) Molecular docking of CGA with Keap1 Kelch , (F) Molecular docking of CA-derivative with Keap1 Kelch , (G) Molecular docking of protocatechuic acid with Keap1 Kelch , (H) Molecular docking of gallic acid with Keap1 Kelch , This figure is exported from the Ligplot software. Hydrogen bonds are shown as green dotted lines, while the spoked arcs represent residues making nonbonded contacts with the ligand. (I) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays of the toxic effects of chlorogenic acid (CGA) on H 2 O 2 -treated H9c2 cells. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to H 2 O 2 group. (J) Western blot and gray value analysis of Keap1 protein expression after treated with different concentrations of CGA. (K) Western blot and gray value analysis of Keap1 protein expression treated with different times of CGA. (L) Western blot and gray value analysis of Keap1 protein expression treated with different concentrations of 60 μM CGA. The results are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group.

Techniques Used: Binding Assay, Software, Western Blot, Expressing, Standard Deviation, Control

Image Search Results

Effects of GW280264X on redox regulatory proteins in liver tissue. ( A ) Kelch-like ECH-associated protein 1 (Keap1), ( B ) nuclear factor erythroid 2 2-related factor 2 (Nrf2), and ( C ) glutathione (GSH) levels. Data are presented as mean ± SEM ( n = 5). * p < 0.05 vs. 0.9% NaCl, # p < 0.05 vs. LPS. Black squares represent individual data points for each animal.

Journal: Life

Article Title: Modulation of Oxidative and ER Stress Pathways by the ADAM17 Inhibitor GW280264X in LPS-Induced Acute Liver Injury

doi: 10.3390/life15121877

Figure Lengend Snippet: Effects of GW280264X on redox regulatory proteins in liver tissue. ( A ) Kelch-like ECH-associated protein 1 (Keap1), ( B ) nuclear factor erythroid 2 2-related factor 2 (Nrf2), and ( C ) glutathione (GSH) levels. Data are presented as mean ± SEM ( n = 5). * p < 0.05 vs. 0.9% NaCl, # p < 0.05 vs. LPS. Black squares represent individual data points for each animal.

Article Snippet: Commercial ELISA kits were used to quantify liver tissue levels of KEAP1 (Cat. No. E2198Mo, BT-Laboratory, Shanghai, China), CHOP (Cat. No. E2718Mo, BT-Laboratory), 4-HNE (Cat. No. E1293Mo, BT-Laboratory), MDA (Cat. No. E0625Mo, BT-Laboratory), NRF2 (Cat. No. E1367Mo, BT-Laboratory), TNF-α (Cat. No. E-EL-M3063, Elabscience, Houston, TX, USA), GRP78 (Cat. No. E-EL-M2696, Elabscience, Houston, TX, USA), glutathione (GSH) colorimetric assay kit (Cat No. E-EL-0026, Elabscience, Houston, TX, USA) and ATF6 (Cat. No. ELK4479, Elk Biotechnology, Wuhan, China).

Techniques:

Journal: Journal of Pharmaceutical Analysis

Article Title: Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation

doi: 10.1016/j.jpha.2025.101219

Figure Lengend Snippet: Caffeic acid (CA) activate kelch-like ECH-associated protein 1/nuclear factor erythroid 2 related factor 2 (Keap1/Nrf2) signaling pathway. (A–E) Western blot and gray value analysis of Keap1 protein expression. (F) Western blot and gray value analysis of Nrf2 protein expression in the nucleus and cytoplasm. (G, H) Representative images of immunofluorescence staining of Keap1 (Green) and Nrf2 (Red). (I) Western blot and gray value analysis of heme oxygenase-1 (HO-1) and nicotinamide adenine dinucleotide phosphate (NADPH) dehydrogenase quinone 1 (NQO1) protein expression. The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group. GAPDH: glyceraldehyde-3-phosphate dehydrogenase; DAPI: 4′,6-diamidino-2′-phenylindole.

Article Snippet: Interaction analysis of caffeic acid (CA) analogs with kelch-like ECH-associated protein 1 (Keap1) Kelch . (A–D) The affinity of Keap1 Kelch binding with different components was detected by Biacore. (A) CGA with Keap1 Kelch , (B) CA-derivative with Keap1 Kelch , (C) Protocatechuic acid with Keap1 Kelch , D) Gallic acid with Keap1 Kelch . (E-H) The CA analogs and Keap1 Kelch interaction diagram. (E) Molecular docking of CGA with Keap1 Kelch , (F) Molecular docking of CA-derivative with Keap1 Kelch , (G) Molecular docking of protocatechuic acid with Keap1 Kelch , (H) Molecular docking of gallic acid with Keap1 Kelch , This figure is exported from the Ligplot software.

Techniques: Western Blot, Expressing, Immunofluorescence, Staining, Standard Deviation, Control

Journal: Journal of Pharmaceutical Analysis

Article Title: Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation

doi: 10.1016/j.jpha.2025.101219

Figure Lengend Snippet: Caffeic acid (CA) induced kelch-like ECH-associated protein 1 (Keap1) degradation via p62-dependent autophagy. (A) Western blot and gray value analysis of Keap1 and p62 protein expression. (B) Immunofluorescence staining of p62 (Red) was analyzed by treating cells with different doses of CA. (C–E) Western blot and gray value analysis of Keap1 and LC3B-II protein expression were conducted both with and without the addition of MG132. (F–H) Western blot and gray value analysis of Keap1 and LC3B-II protein expression were conducted both with and without the addition of CQ (I) The LC3B-II (Red) expression level was detected by immunofluorescence analysis. The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group. DAPI: 4′,6-diamidino-2′-phenylindole; CQ: chloroquin.

Techniques: Western Blot, Expressing, Immunofluorescence, Staining, Standard Deviation, Control

Journal: Journal of Pharmaceutical Analysis

Article Title: Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation

doi: 10.1016/j.jpha.2025.101219

Figure Lengend Snippet: Caffeic acid (CA) directly interacts with kelch-like ECH-associated protein 1 (Keap1) in vit r o . (A) Structure of CA and photo-affinity labeling probe (PAL-CA). (B) PAL-CA probe target fishing flowchart. (C) Silver staining of the PAL-CA complex in H9c2 cells. (D) Validation of Keap1 pulled down from mitochondria of the H9c2 cells with PAL-CA by Western blot. (E) Cellular thermal shift assay (CETSA) experiments of CA with Keap1 protein. (F) Size-exclusion chromatography analysis. The black and red lines represent the ultraviolet absorption of the standard and Keap1 proteins at 280 nM, respectively. (G) Surface plasmon resonance (SPR) experiments of CA with Keap1 protein. (H) Chemical structure of CA (top) and isothermal titration calorimetry (ITC) experiments (bottom). (I, J) SDS-PAGE gel and line graph were used to analyze the in vitro digestive stability of Keap1 under the action of trypsin.. (K) Native mass spectrometry analysis of apo Keap1. The Keap1 protein exists as monomers, dimers, and hexamers in solution (top). Enlarged view of the Keap1 protein dimer, including the P 1 and P 2 peaks (bottom). (L) Native mass spectrometry analysis of Keap1 with CA. After CA binds to the Keap1 protein, the monomers, dimers and hexamers exist in solution (top). Enlarged view of the increased dimerization that occurs after CA binds to the Keap1 protein (P 1 and P 2 peaks) (bottom). The results were normalized and are expressed as the mean ± standard deviation (SD) ( n = 3). DMSO: dimethyl sulfoxide.

Techniques: Labeling, Silver Staining, Biomarker Discovery, Western Blot, Thermal Shift Assay, Size-exclusion Chromatography, SPR Assay, Isothermal Titration Calorimetry, SDS Page, In Vitro, Mass Spectrometry, Standard Deviation

Journal: Journal of Pharmaceutical Analysis

Article Title: Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation

doi: 10.1016/j.jpha.2025.101219

Figure Lengend Snippet: The complexed crystal structure confirms the interaction sites of caffeic acid (CA) with kelch-like ECH-associated protein 1 (Keap1). (A) Schematic design of the experiments. (B) Gel filtration traces of Keap1 and Keap1 gel filtered with CA with a Superdex 200 10/300 Increase column and superimposed on the chromatogram of two standard protein markers (75 kDa and 44 kDa). (C) Kelch crystal diagram. (D) The overall structure of the complex of the Kelch domain with CA. Two orthogonal views are shown. (E) The CA molecule and surrounding residues responsible for its binding are shown in ball-and-stick representation. The M550 and N532 residues of the Kelch domain interact with CA. (F) Isothermal titration calorimetry (ITC) experiments of N532A with Keap1. (G) Comparison of the mouse Kelch domain (PDB ID: 1X2J ) and the Kelch domain bound to CA (PDB ID: 7YEN ). The Kelch apo and Kelch-CA complexes are colored wheat and purple, respectively. (H) Protein-ligand complex structure of molecular dynamics (MD) simulations for wild type 5 ns (a), wild type 100 ns (b), N532A mutant (c), and M550A mutant (d) of Keap1 kelch domain. The ligand CA is shown as yellow sticks. (I) Multiple sequence alignment of Keap1 from different species. The red background represents extremely conserved residues, and the red font represents relatively conserved residues. H. sapiens : Homo sapiens; M. musculus : Mus musculus ; C. toad : Caucasian toad ; D. rerio : Danio rerio .DP: ?.

Techniques: Filtration, Binding Assay, Isothermal Titration Calorimetry, Comparison, Mutagenesis, Sequencing

Journal: Journal of Pharmaceutical Analysis

Article Title: Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation

doi: 10.1016/j.jpha.2025.101219

Figure Lengend Snippet: Interaction analysis of caffeic acid (CA) analogs with kelch-like ECH-associated protein 1 (Keap1) Kelch . (A–D) The affinity of Keap1 Kelch binding with different components was detected by Biacore. (A) CGA with Keap1 Kelch , (B) CA-derivative with Keap1 Kelch , (C) Protocatechuic acid with Keap1 Kelch , D) Gallic acid with Keap1 Kelch . (E-H) The CA analogs and Keap1 Kelch interaction diagram. (E) Molecular docking of CGA with Keap1 Kelch , (F) Molecular docking of CA-derivative with Keap1 Kelch , (G) Molecular docking of protocatechuic acid with Keap1 Kelch , (H) Molecular docking of gallic acid with Keap1 Kelch , This figure is exported from the Ligplot software. Hydrogen bonds are shown as green dotted lines, while the spoked arcs represent residues making nonbonded contacts with the ligand. (I) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays of the toxic effects of chlorogenic acid (CGA) on H 2 O 2 -treated H9c2 cells. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to H 2 O 2 group. (J) Western blot and gray value analysis of Keap1 protein expression after treated with different concentrations of CGA. (K) Western blot and gray value analysis of Keap1 protein expression treated with different times of CGA. (L) Western blot and gray value analysis of Keap1 protein expression treated with different concentrations of 60 μM CGA. The results are expressed as the mean ± standard deviation (SD) ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, compared to the control group.

Techniques: Binding Assay, Software, Western Blot, Expressing, Standard Deviation, Control

Review

Structured Review

Images

1) Product Images from "Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1 N532/M550 and promoting its degradation"

Similar Products

Image Search Results